Yasir B. Al-Wakeel
CIK 1650691 · Chief Financial Officer · last filed 2025-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$56.6K
Companies
4
Total Filings
22
Lifetime Open-Market Net
$67.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MXCT | Director | 50,577 | $1.12 | $56.6K | $0 | 6 | 2025-06-23 |
| Kronos Bio, Inc. (KRON) Delisted | Chief Financial Officer | 346,102 | $0.88 | $304.6K | $67.2K | 7 | 2023-07-07 |
| Neon Therapeutics, Inc. (NTGN) Delisted | Chief Financial Officer | 0 | — | — | $0 | 7 | 2020-05-06 |
| MERRIMACK PHARMACEUTICALS INC (MACK) Delisted | CFO and Head of Corp Dev | — | $15.13 | — | $0 | 2 | 2016-02-10 |
Recent Filings · Page 3 of 3
22 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-10 | MERRIMACK PHARMACEUTICALS INC (MACK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-13 | MERRIMACK PHARMACEUTICALS INC (MACK) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–22 of 22
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.